The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1149
https://www.valueinhealthjournal.com/article/S1098-3015(13)03054-4/fulltext
Title :
The Budget Impact of Introducing Ranibizumab in England and Wales for the Treatment of Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03054-4&doi=10.1016/j.jval.2013.08.1149
First page :
A503
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1003